Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

Pozycja w akcjach #2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Cena akcji
$100.60
Kapitalizacja rynkowa
$7.54B
Zmiana (1 dzień)
-1.49%
Zmiana (1 rok)
49.53%
Kraj
CH
Handel Bachem Holding AG (BANB)

Kategoria

Healthcare
Historia stopy dywidendy dla Bachem Holding AG (BANB)
Stopa dywidendy (TTM) dla Bachem Holding AG (symbol akcji: BANB) na dzień 2024-12-31 wynosi: 1.38%
Średnia stopa dywidendy z ostatnich 5 lat: 0.86%
Historia stopy dywidendy dla Bachem Holding AG (BANB) od 2002 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
2026 (TTM) 1.08% 58.82%
2025 0.68% -50.72%
2024 1.38% 18.97%
2023 1.16% 31.82%
2022 0.88% 340.00%
2021 0.20% -73.68%
2020 0.76% -40.63%
2019 1.28% -27.27%
2018 1.76% 53.04%
2017 1.15% -31.14%
2016 1.67% -31.28%
2015 2.43% -31.93%
2014 3.57% 15.53%
2013 3.09% 50.73%
2012 2.05% -46.19%
2011 3.81% 43.77%
2010 2.65% 11.34%
2009 2.38% -36.36%
2008 3.74% -48.84%
2007 7.31% 348.47%
2006 1.63% 409.38%
2005 0.32% -81.07%
2004 1.69% -92.16%
2003 21.55% -99.40%
2002 3,618.76% 0.00%
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji